Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C

This publication has 24 references indexed in Scilit:

• Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition
  Journal of Biological Chemistry, 2002
• Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B
  Journal of Hepatology, 2001
• Hepatic Stellate Cell Behavior during Resolution of Liver Injury
  Seminars in Liver Disease, 2001
• A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C
  Hepatology, 2001
• Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors
  Gut, 2001
• Regression of Liver Fibrosis after Biliary Drainage in Patients with Chronic Pancreatitis and Stenosis of the Common Bile Duct
  New England Journal of Medicine, 2001
• Impact of Interferon Alfa–2B and Ribavirin on Progression of Liver Fibrosis in Patients With Chronic Hepatitis C
  Hepatology, 2000
• Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
  New England Journal of Medicine, 1998
• Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.
  Journal of Clinical Investigation, 1998
• Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis C
  Hepatology, 1994